TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT05040178: An Observational Study of Carbaglu® for the Treatment of MMA and PA in Adults and Pediatrics

Sponsor: RECORDATI GROUP · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 20 pts

Competing Trials Overlap

5 Active Trials

Excess Burn Exposure

$896,400

Rescue Site Savings

+$597,600

Unlock Full NCT05040178 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT05040178 Rescue Dossier →